Cost Utility of Screening for Barrett's Esophagus With Esophageal Capsule Endoscopy Versus Conventional Upper Endoscopy

Clinical Gastroenterology and Hepatology

Volumn 5, Issue 3, 2007, Pages 312-318

  Rubenstein, Joel H ^a   Inadomi, John M ^b   Brill, Joel V ^c   Eisen, Glenn M ^d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Predictive Health LLC   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER MORTALITY; CAPSULE ENDOSCOPY; CLINICAL FEATURE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; ESOPHAGOSCOPY; HEALTH CARE COST; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; QUALITY ADJUSTED LIFE YEAR;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BARRETT ESOPHAGUS; CAPSULE ENDOSCOPY; COHORT STUDIES; COST-BENEFIT ANALYSIS; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; GASTROESOPHAGEAL REFLUX; HUMANS; INCIDENCE; MALE; MARKOV CHAINS; MASS SCREENING; MIDDLE AGED; QUALITY-ADJUSTED LIFE YEARS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS;

EID: 33947190423     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2006.12.008     Document Type: Article

References (71)

1. Blot W.J., Devesa S.S., Kneller R.W., et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265 (1991) 1287-1289
2. Jemal A., Murray T., Samuels A., et al. Cancer statistics, 2003. CA Cancer J Clin 53 (2003) 5-26
3. Bollschweiler E., Wolfgarten E., Gutschow C., et al. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 92 (2001) 549-555
4. Shaheen N., and Ransohoff D.F. Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: scientific review. JAMA 287 (2002) 1972-1981
5. Lagergren J., Bergstrom R., Lindgren A., et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340 (1999) 825-831
6. Sampliner R.E. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 97 (2002) 1888-1895
7. Wang K.K., Wongkeesong M., Buttar N.S., et al. American Gastroenterological Association medical position statement: role of the gastroenterologist in the management of esophageal carcinoma. Gastroenterology 128 (2005) 1468-1470
8. Armstrong D., Marshall J.K., Chiba N., et al. Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults: update 2004. Can J Gastroenterol 19 (2005) 15-35
9. Waring J.P., Baron T.H., Hirota W.K., et al. Guidelines for conscious sedation and monitoring during gastrointestinal endoscopy. Gastrointest Endosc 58 (2003) 317-322
10. Eliakim R.M.D., Sharma V.K.M.D., Yassin K.M.D., et al. A prospective study of the diagnostic accuracy of PillCam ESO esophageal capsule endoscopy versus conventional upper endoscopy in patients with chronic gastroesophageal reflux diseases. J Clin Gastroenterol 39 (2005) 572-578
11. Koslowsky B., Jacob H., Eliakim R., et al. PillCam ESO in esophageal studies: improved diagnostic yield of 14 frames per second (fps) compared with 4 fps. Endoscopy 38 (2006) 27-30
12. Sharma P., Rastogi A., Esquivel R., et al. Accuracy of wireless capsule endoscopy for the detection of Barrett's esophagus. Gastroenterology 130 (2006) A262
13. Lin O., Schembre D., and Kozarek R. Blinded comparison of esophageal capsule endoscopy versus conventional endoscopy for diagnosis of Barrett's esophagus in patients with chronic gastroesophageal reflux. (abstract). Gastrointest Endosc 63 (2006) AB103
14. Inadomi J.M., Sampliner R., Lagergren J., et al. Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis. Ann Intern Med 138 (2003) 176-186
15. Portale G., Peters J.H., Hagen J.A., et al. Comparison of the clinical and histological characteristics and survival of distal esophageal-gastroesophageal junction adenocarcinoma in patients with and without barrett mucosa. Arch Surg 140 (2005) 570-574
16. Silvis S.E., Nebel O., Rogers G., et al. Endoscopic complications: results of the 1974 American Society for Gastrointestinal Endoscopy survey. JAMA 235 (1976) 928-930
17. Habr-Gama A., and Waye J.D. Complications and hazards of gastrointestinal endoscopy. World J Surg 13 (1989) 193-201
18. Giuli R., Rudiger Siewert J., and Couturier D. Barrett's esophagus: columnar lined esophagus Volume 1 (2003), John Libbey Eurotext Limited, Esther, Surrey, UK 434
19. Sharma P., McQuaid K., Dent J., et al. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology 127 (2004) 310-330
20. Rex D.K., Cummings O.W., Shaw M., et al. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology 125 (2003) 1670-1677
21. Ward E.M., Wolfsen H.C., Achem S.R., et al. Barrett's esophagus is common in older men and women undergoing screening colonoscopy regardless of reflux symptoms. Am J Gastroenterol 101 (2006) 12-17
22. Eloubeidi M.A., and Provenzale D. Does this patient have Barrett's esophagus?. the utility of predicting Barrett's esophagus at the index endoscopy. Am J Gastroenterol 94 (1999) 937-943
23. Connor M.J., Weston A.P., Mayo M.S., et al. The prevalence of Barrett's esophagus and erosive esophagitis in patients undergoing upper endoscopy for dyspepsia in a VA population. Dig Dis Sci 49 (2004) 920-924
24. Gerson L.B., Shetler K., and Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 123 (2002) 461-467
25. US Bureau of Economic Analysis. State personal income 2005. Available at: http://www.bea.gov/bea/newsrel/SPINewsRelease.htm. Accessed May 4, 2006.
26. Rubenstein J.H., and Inadomi J.M. Defining a clinically significant adverse impact of diagnosing Barrett's esophagus. J Clin Gastroenterol 40 (2006) 109-115
27. Gold M.R., Siegel J.E., and Russell L.B. Cost-effectiveness in health and medicine (1996), Oxford University Press, New York
28. Ubel P.A., Hirth R.A., Chernew M.E., et al. What is the price of life and why doesn't it increase at the rate of inflation?. Arch Intern Med 163 (2003) 1637-1641
29. Peters J.H., Clark G.W., Ireland A.P., et al. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 108 (1994) 813-821
30. Streitz Jr. J.M., Andrews Jr. C.W., and Ellis Jr. F.H. Endoscopic surveillance of Barrett's esophagus: does it help?. J Thorac Cardiovasc Surg 105 (1993) 383-387
31. Corley D.A., Levin T.R., Habel L.A., et al. Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology 122 (2002) 633-640
32. van Sandick J.W., van Lanschot J.J., Kuiken B.W., et al. Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut 43 (1998) 216-222
33. Hirota W.K., Loughney T.M., Lazas D.J., et al. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 116 (1999) 277-285
34. Bonelli L. Barrett's esophagus: results of a multicentric survey-GOSPE (Gruppo Operativo per lo Studio delle Precancerosi Esofagee. Endoscopy 25 (1993) 652-654
35. Winters Jr. C., Spurling T.J., Chobanian S.J., et al. Barrett's esophagus: a prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 92 (1987) 118-124
36. Weston A.P., Krmpotich P., Makdisi W.F., et al. Short segment Barrett's esophagus: clinical and histological features, associated endoscopic findings, and association with gastric intestinal metaplasia. Am J Gastroenterol 91 (1996) 981-986
37. Caygill C.P., Reed P.I., Hill M.J., et al. An initial comparison of nine centres registering patients with the UK National Barrett's Oesophagus Registry (UKBOR). Eur J Cancer Prev 8 (1999) 539-542
38. Johnston M.H., Hammond A.S., Laskin W., et al. The prevalence and clinical characteristics of short segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy. Am J Gastroenterol 91 (1996) 1507-1511
39. Hameeteman W., Tytgat G.N., Houthoff H.J., et al. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 96 (1989) 1249-1256
40. O'Connor J.B., Falk G.W., and Richter J.E. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. Am J Gastroenterol 94 (1999) 2037-2042
41. Sharma P., Morales T.G., Bhattacharyya A., et al. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up. Am J Gastroenterol 92 (1997) 2012-2016
42. Schnell T.G., Sontag S.J., Chejfec G., et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 120 (2001) 1607-1619
43. Soni A., Sampliner R.E., and Sonnenberg A. Screening for high-grade dysplasia in gastroesophageal reflux disease: is it cost-effective?. Am J Gastroenterol 95 (2000) 2086-2093
44. Weston A.P., Badr A.S., and Hassanein R.S. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma. Am J Gastroenterol 94 (1999) 3413-3419
45. Drewitz D.J., Sampliner R.E., and Garewal H.S. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 92 (1997) 212-215
46. Caygill C.P., Reed P.I., Johnston B.J., et al. A single centre's 20 years' experience of columnar-lined (Barrett's) oesophagus diagnosis. Eur J Gastroenterol Hepatol 11 (1999) 1355-1358
47. Spechler S.J., Robbins A.H., Rubins H.B., et al. Adenocarcinoma and Barrett's esophagus: an overrated risk?. Gastroenterology 87 (1984) 927-933
48. Cameron A.J., Ott B.J., and Payne W.S. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 313 (1985) 857-859
49. Williamson W.A., Ellis Jr. F.H., Gibb S.P., et al. Barrett's esophagus: prevalence and incidence of adenocarcinoma. Arch Intern Med 151 (1991) 2212-2216
50. Sharma P., Reker D., Falk G., et al. Progression of Barrett's esophagus to high grade dysplasia and cancer: preliminary results of the BEST (Barrett's Esophagus Study) trial. (abstract). Gastroenterology 120 (2001) 16
51. Dent J., Bremner C.G., Collen M.J., et al. Barrett's oesophagus. J Gastroenterol Hepatol 6 (1991) 1-22
52. Katz D., Rothstein R., Schned A., et al. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus. Am J Gastroenterol 93 (1998) 536-541
53. Schoenfeld P., Johnston M., Piorkowski M., et al. Effectiveness and patient satisfaction with nurse-directed treatment of Barrett's esophagus. Am J Gastroenterol 93 (1998) 906-910
54. Weston A.P., Sharma P., Topalovski M., et al. Long-term follow-up of Barrett's high-grade dysplasia. Am J Gastroenterol 95 (2000) 1888-1893
55. Robertson C.S., Mayberry J.F., Nicholson D.A., et al. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus. Br J Surg 75 (1988) 760-763
56. Weston A.P., Badr A.S., and Hassanein R.S. Prospective multivariate analysis of factors predictive of complete regression of Barrett's esophagus. Am J Gastroenterol 94 (1999) 3420-3426
57. Menke-Pluymers M.B., Schoute N.W., Mulder A.H., et al. Outcome of surgical treatment of adenocarcinoma in Barrett's oesophagus. Gut 33 (1992) 1454-1458
58. Ellis Jr. F.H., Heatley G.J., Krasna M.J., et al. Esophagogastrectomy for carcinoma of the esophagus and cardia: a comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria. Jo Thorac Cardiovasc Surg 113 (1997) 836-848
59. Skinner D.B. En bloc resection for neoplasms of the esophagus and cardia. J Thorac Cardiovasc Surg 85 (1983) 59-71
60. Ellis Jr. F.H., Gibb S.P., and Watkins Jr. E. Esophagogastrectomy: a safe, widely applicable, and expeditious form of palliation for patients with carcinoma of the esophagus and cardia. Ann Surg 198 (1983) 531-540
61. Nguyen N.T., Schauer P., and Luketich J.D. Minimally invasive esophagectomy for Barrett's esophagus with high-grade dysplasia. Surgery 127 (2000) 284-290
62. Wolfe W.G., Vaughn A.L., Seigler H.F., et al. Survival of patients with carcinoma of the esophagus treated with combined-modality therapy. J Thorac Cardiovasc Surg 105 (1993) 749-756
63. Galandiuk S., Hermann R.E., Cosgrove D.M., et al. Cancer of the esophagus: the Cleveland Clinic experience. Ann Surg 203 (1986) 101-108
64. DeMeester T.R., Zaninotto G., and Johansson K.E. Selective therapeutic approach to cancer of the lower esophagus and cardia. J Thorac Cardiovasc Surg 95 (1988) 42-54
65. Wu Y.K., and Huang K.C. Chinese experience in the surgical treatment of carcinoma of the esophagus. Ann Surg 190 (1979) 361-365
66. Earlam R., and Cunha-Melo J.R. Oesophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg 67 (1980) 381-390
67. Pera M., Trastek V.F., Carpenter H.A., et al. Barrett's esophagus with high-grade dysplasia: an indication for esophagectomy?. Ann Thorac Surg 54 (1992) 199-204
68. National Center for Health Statistics. Vital statistics of the United States (2000), US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, Division of Data Services, 2001, Hyattsville, MD
69. Provenzale D., Schmitt C., and Wong J.B. Barrett's esophagus: a new look at the surveillance based on emerging estimates of cancer risk. Am J Gastroenterol 94 (1999) 2043-2053
70. Provenzale D., Kemp A., Arora S., et al. A guide for surveillance of patients with Barrett's esophagus. Am J Gastroenterol 89 (1994) 670-680
71. Gerson L.B., Groeneveld P.W., and Triadafilopoulos G. Cost-effectiveness model of endoscopic screening and surveillance in patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatology 2 (2004) 868-879